TREATMENT OF BENIGN NERVOUS SYSTEM TUMORS USING ATTENUATED SALMONELLA TYPHIMURIUM Application EP-3930745-A4 European Patent Office 20 Jul 2022
Compounds and methods for kinase modulation, and indications therefor Grant US-11337976-B2 United States of America 24 May 2022
TREATMENT OF BENIGN NERVOUS SYSTEM TUMORS USING ATTENUATED SALMONELLA TYPHIMURIUM Application WO-2020176764-A1 World Intellectual Property Organisation (WIPO) 03 Sep 2020
NON-HUMAN MODEL FOR NEUROFIBROMATOSIS TYPE 1 Application WO-2019002590-A1 World Intellectual Property Organisation (WIPO) 03 Jan 2019
NON-HUMAN MODEL FOR NEUROFIBROMATOSIS TYPE 1 Application EP-3420811-A1 European Patent Office 02 Jan 2019
Compounds and methods for kinase modulation, and indications therefor Grant US-9624213-B2 United States of America 18 Apr 2017
Compounds modulating c-fms and/or c-kit activity and uses therefor Grant US-9487515-B2 United States of America 08 Nov 2016
Compounds modulating c-fms and/or c-kit activity and uses therefor Grant US-9169250-B2 United States of America 27 Oct 2015
Compounds and methods for kinase modulation, and indications therefor Grant US-9096593-B2 United States of America 04 Aug 2015
Compounds modulating c-fms and/or c-kit activity and uses therefor Grant US-8722702-B2 United States of America 13 May 2014